The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.

Saved in:
Bibliographic Details
Title: The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
Authors: Sjöström M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA.; Division of Oncology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden., Zhao SG; Department of Human Oncology, University of Wisconsin-Madison, Madison, WI.; William S. Middleton Memorial Veterans' Hospital, Madison, WI., Levy S; Bluestar Genomics Inc., San Diego, CA., Zhang M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA., Ning Y; Bluestar Genomics Inc., San Diego, CA., Shrestha R; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA., Lundberg A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA., Herberts C; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Foye A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA., Aggarwal R; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA., Hua JT; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA., Li H; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA., Bergamaschi A; Bluestar Genomics Inc., San Diego, CA., Maurice-Dror C; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; BC Cancer, Vancouver, BC, Canada., Maheshwari A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA., Chen S; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Ng SWS; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Ye W; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Automation, Xiamen University, Xiamen, Fujian, China., Petricca J; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Fraser M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Chesner L; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA., Perry MD; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA., Moreno-Rodriguez T; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA., Chen WS; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA., Alumkal JJ; Division of Hematology and Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI., Chou J; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA., Morgans AK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Beer TM; Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Thomas GV; Knight Cancer Institute, Oregon Health and Science University, Portland, OR.; Department of Pathology, Oregon Health & Science University, Portland, OR., Gleave M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Lloyd P; Bluestar Genomics Inc., San Diego, CA., Phillips T; Bluestar Genomics Inc., San Diego, CA., McCarthy E; Bluestar Genomics Inc., San Diego, CA., Haffner MC; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA.; University of Washington, Seattle, WA., Zoubeidi A; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Annala M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland., Reiter RE; Departments of Medicine, Hematology/Oncology and Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA., Rettig MB; Departments of Medicine, Hematology/Oncology and Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA.; VA Greater Los Angeles Healthcare System, Los Angeles, CA., Witte ON; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA., Fong L; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA., Bose R; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.; Department of Urology, University of California, San Francisco, San Francisco, CA.; Department of Anatomy, University of California, San Francisco, San Francisco, CA., Huang FW; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA., Luo J; Department of Pathology, University of Pittsburgh, Pittsburgh, PA., Bjartell A; Department of Translational Medicine, Medical Faculty, Lund University, Malmö, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden., Lang JM; Department of Medicine, University of Wisconsin-Madison, Madison, WI., Mahajan NP; Siteman Cancer Center, Washington University, St. Louis, MO., Lara PN; Division of Hematology Oncology, Department of Internal Medicine, University of California Davis, Sacramento, CA.; Comprehensive Cancer Center, University of California Davis, Sacramento, CA., Evans CP; Comprehensive Cancer Center, University of California Davis, Sacramento, CA.; Department of Urologic Surgery, University of California Davis, Sacramento, CA., Tran PT; Department of Radiation Oncology, University of Maryland, College Park, Baltimore, MD., Posadas EM; Urologic Oncology Program & Uro-Oncology Research Laboratories, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA., He C; Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL.; Howard Hughes Medical Institute, University of Chicago, Chicago, IL., Cui XL; Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL.; Howard Hughes Medical Institute, University of Chicago, Chicago, IL., Huang J; Department of Pathology, Duke University, Durham, NC., Zwart W; Netherlands Cancer Institute, Oncode Institute, Amsterdam, the Netherlands., Gilbert LA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Urology, University of California, San Francisco, San Francisco, CA.; Arc Institute, Palo Alto, CA., Maher CA; Siteman Cancer Center, Washington University, St. Louis, MO.; McDonnell Genome Institute, Washington University, St. Louis, MO.; Department of Internal Medicine, Washington University, St. Louis, MO.; Department of Biomedical Engineering, Washington University, St. Louis, MO., Boutros PC; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Department of Human Genetics, Institute for Precision Health, UCLA, Los Angeles, CA.; Jonsson Comprehensive Cancer Center, Departments of Human Genetics and Urology, University of California Los Angeles, Los Angeles, CA., Chi KN; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Ashworth A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA., Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA., He HH; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada., Quigley DA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Urology, University of California, San Francisco, San Francisco, CA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA., Feng FY; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.; Department of Urology, University of California, San Francisco, San Francisco, CA.
Source: Cancer research [Cancer Res] 2022 Nov 02; Vol. 82 (21), pp. 3888-3902.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-22-1123